NK cells from three healthy individuals were cultured with a HER2-overexpressing gastric cancer cell line (GLM4) in the presence of different concentrations of trastuzumab and pertuzumab (0–10 μg/mL) (Fig 5A). This evidence concerns the gene ERBB2 and gastric cancer.